Timeliness and actionable intelligence over I-Banks research which remains only geared to institutional investors and legacy processes. News carries with it a promise of transparency, a light that can be shined into previously dark corners.
But they don’t define any relevance to the actual value of a release - mostly due to SEC forward looking parameters. However, this news portal has been expanded to … supplement, measure and price the event and relevance to a company’s ... valuation.
October 20, 2022
Prime Medicine (PRME) a gene editing company has raised $175 million selling 1.4 million shares in the middle of its $17-$19 price range in its IPO
October 19, 2022
Avrobio (AVRO) received De-Listing Notice for being under $1.00 compliance with Nasdaq, has 180 days to correct
September 30, 2022
Solid Biosciences (SLDB) announces acquisition of Aavanti Bio Inc (private)and concurrent $75 Million Private Placement
September 28, 2022
RegMed Investors’ (RMi): What’s up Applied Genetic Technologies (AGTC)?
September 16, 2022
The Biostage (BSTG) Chronicles: Who is or what is behind the purchases and pump/promote of BSTG’s volume and share pricing?
August 30, 2022
RegMed Investors (RMI): burning investors, Applied Genetic Technologies (AGTC)
August 16, 2022
RegMed Investors’ (RMI) Earnings: dates of releases and more results
July 21, 2022
Verve Therapeutics (VERV) proposes $200 M offering priced at $27.00
July 13, 2022
Applied Genetic Technologies (AGTC) prices public offering of 16,66 M shares at $0.60
June 23, 2022
The Biostage (BSTG) Chronicles: filed an S-1 preliminary offering prospectus by Newbridge Securities Corporation.
May 3, 2022
RegMed Investors: The week that will define the cell and gene therapy sector’s share pricing month
April 28, 2022
The Biostage (BSTG) Chronicles: Surgeon on trial in Sweden over experimental windpipe transplants
April 28, 2022
Alnylam Pharmaceuticals (ALNY) reports Q1/2022 earnings; net loss and net product revenue and collaboration decreases
April 27, 2022
Solid BioSciences (SLDB) reports Q1 and announcing 35% of employee layoffs
April 26, 2022
RegMed Investors Earnings: We are getting close to Q2 reporting season
April 16, 2022
Warmest holy day wishes!
April 16, 2022
Warmest holyday wishes ….
March 22, 2022
Applied Genetic Technology (AGTC) prices 7.5 M share public offering
March 4, 2022
UC Berkeley loses CRISPR patent case, invalidating licenses it granted gene-editing companies
February 17, 2022
The Biostage (OTC: QB: BSTG) Chronicles: Who, What, When, Where, Why and one H (HOW)
January 11, 2022
The Biostage Chronicles: dispose and disregard, fit for the barrel
December 15, 2021
Global Blood Therapeutics (GBT) increases, prices and closes private offering of $300 million Convertible Senior Notes due 2028
December 4, 2021
RegMed Investors (RMi): The week in review …
6 hours 14 min ago
RegMed Investors (RMi) Closing Bell: welcoming the upside trend
15 hours 14 min ago
RegMed Investors’ (RMi) pre-open: finding our way
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors